Citalopram: Clinical Trials

177 trials of Citalopram, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

124 completed, 26 unknown, 11 terminated, 8 withdrawn. 49 Phase 4, 35 Not applicable, 33 Phase 2, 27 Phase 1, 21 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 449Completed 29, Unknown 9, Terminated 6, Withdrawn 3, Active not recruiting 1, Not yet recruiting 1
Not applicable35Completed 22, Unknown 9, Recruiting 2, Terminated 1, Withdrawn 1
Phase 233Completed 27, Terminated 2, Unknown 2, Withdrawn 2
Phase 127Completed 24, Withdrawn 2, Unknown 1
Phase 321Completed 16, Unknown 3, Terminated 1, Withdrawn 1
Early Phase 15Completed 2, Unknown 2, Not yet recruiting 1

Follow Citalopram: new trials by email Literature Review of Citalopram trials Research Report on Citalopram

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Deprescription of Antidepressants in Primary Care (DAPriCare)
Deprescription of Antidepressants (fluoxetine, citalopram, sertraline, paroxetine, and escitalopram) - Deprescription, Antidepressants
Early Phase 1Not yet recruitingUniversity of Huelva3252026-06-012026-05-04
Pupillometry in Delayed Sleep Wake Phase Disorder
Light and Citalopram - Delayed Sleep-Wake Phase Disorder
Not applicableRecruitingNorthwestern University2202025-09-012026-06-08
Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.
Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram),, Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants,, Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine - Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder
Phase 4Active not recruitingDr. Stavroula Rakitzi842025-06-042026-05-01
7T Amygdala and Citalopram Study
Citalopram, Placebo - Emotional Processing, Cognition
Not applicableRecruitingUniversity of Oxford542025-02-132026-10-02
Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants
SSRI - Depression, Inflammation
CompletedGermans Trias i Pujol Hospital502024-04-012026-09-14
Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions
Cannabidiol, Placebo, Citalopram - Cannabidiol, Drug Induced Liver Injury
Phase 1CompletedFood and Drug Administration (FDA)2412024-02-082025-07-31
DRACULA1 Partum Depression: an Integrated Molecular-pharmaco-imaging Study")
Citalopram - Post-partum Depression
UnknownFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico152024-01-012023-11-14
Efficacy of Hydroxyzine for Patients With Panic Disorder
Hydroxyzine, Escitalopram Oxalate - Panic Disorder
Phase 4Not yet recruitingSultan Qaboos University802023-12-302023-02-21
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Fezolinetant, Paroxetine, Citalopram - Hot Flashes
CompletedAstellas Pharma Global Development, Inc.9992023-11-152026-06-05
REward Processing And Citalopram Study
Citalopram 20mg, Placebo - Anhedonia
Phase 1 / Phase 2UnknownUniversity of Oxford402023-05-192023-08-30
Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome
Vortioxetine 20Mg Tab, Paroxetine 20 Mg Oral Tablet, Sertraline 50 MG - Burning Mouth Syndrome
Phase 3UnknownFederico II University2032023-01-012023-09-06
Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder
Antidepressant - Major Depressive Disorder
CompletedMental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital733362022-10-012023-08-18
Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression
Citalopram, Psychotherapy - Breast Cancer, Major Depressive Episode
Phase 2TerminatedHospital Universitari de Bellvitge402022-05-102022-07-05
Effect of Citalopram on Chest Pain in Patients With Functional Chest Pain
Citalopram 20mg, Placebo - Functional Chest Pain
Phase 4TerminatedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)12022-01-172023-02-21
Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder
Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg, Citalopram (tablet) 20 mg + Placebo (tablet) - Major Depressive Disorder
Phase 1 / Phase 2CompletedHawler Medical University1002021-11-102022-09-07
SSRIs and TDCS Enhance Post-stroke Motor Recovery
tDCS, Citalopram, Rehabilitation - Stroke, Motor
Phase 3UnknownChih-Wei Tang802021-09-012021-09-13
Combined Antidepressant and Behavioural Intervention
Citalopram, Behavioural Activation, Placebo - Low Mood, Depression
Not applicableCompletedUniversity of Oxford1342021-05-282024-05-21
Electronic Training of Elderly Depression With Cognitive Impairment
Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram) - Geriatric Depression, Cognitive Impairment
Not applicableCompletedCapital Medical University1282021-05-182024-07-16
Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease
Citalopram 20mg, Placebo - Parkinson Disease
Phase 2CompletedUniversity of Michigan582021-04-012026-03-16
Myofascial Pain Patients' Response to the Administration of Low Doses of Amitriptyline and Citalopram Compared With the Use of Bite Splint
Citalopram 10 MG, Amitriptyline, Bite Splint - Muscle Type Temporomandibular Disorders, Myofascial Pain of the Masticatory Muscles
Phase 2 / Phase 3UnknownUniversity of Coimbra802021-03-012021-03-02

Showing 20 of 177. Sign in to see all of them.

Conditions studied

Depression (61)  ·  Depressive Disorder, Major (37)  ·  Depressive Disorder (14)  ·  Anxiety Disorders (10)  ·  Dementia (7)  ·  Schizophrenia (6)  ·  Mental Disorders (5)  ·  Stroke (5)  ·  Alcoholism (4)  ·  Alzheimer Disease (4)  ·  Cocaine-Related Disorders (4)  ·  Gastroesophageal Reflux (4)  ·  Hot Flashes (4)  ·  Mood Disorders (4)  ·  Obsessive-Compulsive Disorder (4)

Sponsors

New York State Psychiatric Institute (9)  ·  University of Oxford (7)  ·  Massachusetts General Hospital (5)  ·  University of Pittsburgh (5)  ·  National Institute of Mental Health (NIMH) (4)  ·  Sunnybrook Health Sciences Centre (4)  ·  Actavis Inc. (3)  ·  Mayo Clinic (3)  ·  University of Michigan (3)  ·  Capital Medical University (2)  ·  China Academy of Chinese Medical Sciences (2)  ·  Dr. Reddy's Laboratories Limited (2)  ·  Duke University (2)  ·  Forest Laboratories (2)  ·  Hospital Universitari de Bellvitge (2)

Countries

United States (74)  ·  Canada (23)  ·  United Kingdom (14)  ·  Germany (9)  ·  Spain (6)  ·  China (5)  ·  Belgium (4)  ·  Denmark (4)  ·  France (4)  ·  India (4)  ·  Italy (4)  ·  Norway (4)  ·  Brazil (2)  ·  Greece (2)  ·  Israel (2)

Top investigators

Benoit Girard, M.D (2)  ·  Carl Gommoll, MS (2)  ·  Frederick G Moeller, M.D. (2)  ·  Knut Engedal, Ph D (2)  ·  Krista L Lanctot, PhD (2)  ·  Lon Schneider, MD (2)  ·  Michael E Henry, MD (2)  ·  Robert M. Anthenelli, MD (2)  ·  A. John Rush, MD (1)  ·  Alan Rios-Espinosa, M.D. (1)  ·  Alan Wade, MG (1)  ·  Albert Pinhasov, PhD (1)  ·  Alfredo N Rivera, MD (1)

Results publications

PMID 36999619, PMID 13688369, PMID 16390886, PMID 16426099, PMID 16457894, PMID 16551710, PMID 16554525, PMID 16554526, PMID 16566612, PMID 16566901, PMID 16636629, PMID 16642436, PMID 16690084, PMID 16754414, PMID 16816220, PMID 16824617, PMID 16946176, PMID 16946177, PMID 17035647, PMID 17074942, PMID 17091129, PMID 17195602, PMID 17302619, PMID 17613964, PMID 17984395, PMID 18162025, PMID 18291293, PMID 18314433, PMID 18465388, PMID 18519523, PMID 18678792, PMID 18681756, PMID 19026268, PMID 19182688, PMID 19183470, PMID 19192454, PMID 19192468, PMID 19223438, PMID 19339358, PMID 19341509, PMID 19358791, PMID 19369318, PMID 19460188, PMID 19485586, PMID 19487623, PMID 19493369, PMID 19574030, PMID 19578654, PMID 19653973, PMID 19730273

NIH funding

P50DA009262 (3), 2009 (2), 2019 (2), R01MH059666 (2), 2014 (1), 2016 (1), 2017 (1), 2018 (1), K23MH081285 (1), K23MH085236 (1), K23NS055733 (1), N01MH090001 (1), N01MH90001 (1), P01HL040962 (1), R01AA013303 (1)